
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
Shelbi Christgen, Min Zheng, Sannula Kesavardhana, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 374
Shelbi Christgen, Min Zheng, Sannula Kesavardhana, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 374
Showing 1-25 of 374 citing articles:
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death
Damien Bertheloot, Eicke Latz, Bernardo S. Franklin
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1106-1121
Open Access | Times Cited: 1367
Damien Bertheloot, Eicke Latz, Bernardo S. Franklin
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1106-1121
Open Access | Times Cited: 1367
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, et al.
Cell (2020) Vol. 184, Iss. 1, pp. 149-168.e17
Open Access | Times Cited: 1275
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, et al.
Cell (2020) Vol. 184, Iss. 1, pp. 149-168.e17
Open Access | Times Cited: 1275
NLRP3 inflammasome in cancer and metabolic diseases
Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Nature Immunology (2021) Vol. 22, Iss. 5, pp. 550-559
Open Access | Times Cited: 750
Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Nature Immunology (2021) Vol. 22, Iss. 5, pp. 550-559
Open Access | Times Cited: 750
Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 503
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 503
Inflammation and aging: signaling pathways and intervention therapies
Xia Li, Chentao Li, Wanying Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 486
Xia Li, Chentao Li, Wanying Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 486
AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence
SangJoon Lee, Rajendra Karki, Yaqiu Wang, et al.
Nature (2021) Vol. 597, Iss. 7876, pp. 415-419
Open Access | Times Cited: 433
SangJoon Lee, Rajendra Karki, Yaqiu Wang, et al.
Nature (2021) Vol. 597, Iss. 7876, pp. 415-419
Open Access | Times Cited: 433
The regulation of the ZBP1‐NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)
Min Zheng, Thirumala‐Devi Kanneganti
Immunological Reviews (2020) Vol. 297, Iss. 1, pp. 26-38
Open Access | Times Cited: 345
Min Zheng, Thirumala‐Devi Kanneganti
Immunological Reviews (2020) Vol. 297, Iss. 1, pp. 26-38
Open Access | Times Cited: 345
The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
Parimal Samir, R. K. Subbarao Malireddi, Thirumala‐Devi Kanneganti
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 342
Parimal Samir, R. K. Subbarao Malireddi, Thirumala‐Devi Kanneganti
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 342
From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways
Yaqiu Wang, Thirumala‐Devi Kanneganti
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4641-4657
Open Access | Times Cited: 342
Yaqiu Wang, Thirumala‐Devi Kanneganti
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4641-4657
Open Access | Times Cited: 342
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Rajendra Karki, Thirumala‐Devi Kanneganti
Trends in Immunology (2021) Vol. 42, Iss. 8, pp. 681-705
Open Access | Times Cited: 269
Rajendra Karki, Thirumala‐Devi Kanneganti
Trends in Immunology (2021) Vol. 42, Iss. 8, pp. 681-705
Open Access | Times Cited: 269
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
Rajendra Karki, Balamurugan Sundaram, Bhesh Raj Sharma, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109858-109858
Open Access | Times Cited: 257
Rajendra Karki, Balamurugan Sundaram, Bhesh Raj Sharma, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109858-109858
Open Access | Times Cited: 257
Programming inflammatory cell death for therapy
Shelbi Christgen, Rebecca E. Tweedell, Thirumala‐Devi Kanneganti
Pharmacology & Therapeutics (2021) Vol. 232, pp. 108010-108010
Open Access | Times Cited: 194
Shelbi Christgen, Rebecca E. Tweedell, Thirumala‐Devi Kanneganti
Pharmacology & Therapeutics (2021) Vol. 232, pp. 108010-108010
Open Access | Times Cited: 194
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
SangJoon Lee, Rudragouda Channappanavar, Thirumala‐Devi Kanneganti
Trends in Immunology (2020) Vol. 41, Iss. 12, pp. 1083-1099
Open Access | Times Cited: 185
SangJoon Lee, Rudragouda Channappanavar, Thirumala‐Devi Kanneganti
Trends in Immunology (2020) Vol. 41, Iss. 12, pp. 1083-1099
Open Access | Times Cited: 185
PANoptosis in microbial infection
David E. Place, SangJoon Lee, Thirumala‐Devi Kanneganti
Current Opinion in Microbiology (2020) Vol. 59, pp. 42-49
Open Access | Times Cited: 181
David E. Place, SangJoon Lee, Thirumala‐Devi Kanneganti
Current Opinion in Microbiology (2020) Vol. 59, pp. 42-49
Open Access | Times Cited: 181
ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection
Rajendra Karki, SangJoon Lee, Raghvendra Mall, et al.
Science Immunology (2022) Vol. 7, Iss. 74
Open Access | Times Cited: 180
Rajendra Karki, SangJoon Lee, Raghvendra Mall, et al.
Science Immunology (2022) Vol. 7, Iss. 74
Open Access | Times Cited: 180
NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs
Balamurugan Sundaram, Pandian Nagakannan, Raghvendra Mall, et al.
Cell (2023) Vol. 186, Iss. 13, pp. 2783-2801.e20
Open Access | Times Cited: 172
Balamurugan Sundaram, Pandian Nagakannan, Raghvendra Mall, et al.
Cell (2023) Vol. 186, Iss. 13, pp. 2783-2801.e20
Open Access | Times Cited: 172
Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection
Min Zheng, Evan P. Williams, R. K. Subbarao Malireddi, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 41, pp. 14040-14052
Open Access | Times Cited: 171
Min Zheng, Evan P. Williams, R. K. Subbarao Malireddi, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 41, pp. 14040-14052
Open Access | Times Cited: 171
Therapeutic modulation of inflammasome pathways
Dhruv Chauhan, Lieselotte Vande Walle, Mohamed Lamkanfi
Immunological Reviews (2020) Vol. 297, Iss. 1, pp. 123-138
Open Access | Times Cited: 170
Dhruv Chauhan, Lieselotte Vande Walle, Mohamed Lamkanfi
Immunological Reviews (2020) Vol. 297, Iss. 1, pp. 123-138
Open Access | Times Cited: 170
Innate immunological pathways in COVID-19 pathogenesis
Søren R. Paludan, Trine H. Mogensen
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 161
Søren R. Paludan, Trine H. Mogensen
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 161
STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)
Yasmine Messaoud‐Nacer, Elodie Culerier, Stéphanie Rose, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 150
Yasmine Messaoud‐Nacer, Elodie Culerier, Stéphanie Rose, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 150
ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis)
Balaji Banoth, Shraddha Tuladhar, Rajendra Karki, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 52, pp. 18276-18283
Open Access | Times Cited: 142
Balaji Banoth, Shraddha Tuladhar, Rajendra Karki, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 52, pp. 18276-18283
Open Access | Times Cited: 142
Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Y. Rajesh, Thirumala‐Devi Kanneganti
Cells (2022) Vol. 11, Iss. 12, pp. 1885-1885
Open Access | Times Cited: 142
Y. Rajesh, Thirumala‐Devi Kanneganti
Cells (2022) Vol. 11, Iss. 12, pp. 1885-1885
Open Access | Times Cited: 142
Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth
R. K. Subbarao Malireddi, Rajendra Karki, Balamurugan Sundaram, et al.
ImmunoHorizons (2021) Vol. 5, Iss. 7, pp. 568-580
Open Access | Times Cited: 136
R. K. Subbarao Malireddi, Rajendra Karki, Balamurugan Sundaram, et al.
ImmunoHorizons (2021) Vol. 5, Iss. 7, pp. 568-580
Open Access | Times Cited: 136
PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality
Pandian Nagakannan, Thirumala‐Devi Kanneganti
The Journal of Immunology (2022) Vol. 209, Iss. 9, pp. 1625-1633
Open Access | Times Cited: 131
Pandian Nagakannan, Thirumala‐Devi Kanneganti
The Journal of Immunology (2022) Vol. 209, Iss. 9, pp. 1625-1633
Open Access | Times Cited: 131
Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment
Peng Zhu, Zhuo-Ran Ke, Jing-Xian Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 103
Peng Zhu, Zhuo-Ran Ke, Jing-Xian Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 103